Patents by Inventor Jerry Bryant

Jerry Bryant has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220369615
    Abstract: This weeding tool is designed to make removing weeds with centralized, non-distributed root systems easy. The tip is designed for easy insertion into even fairly compact soil conditions that are difficult for many other tools of a similar nature. The unique features of this tool versus other tools of a similar nature is the tip length may be changed in a manner that no other tool of a similar nature has, to optimize the tool for the weeding conditions, and the tip itself can be changed out for other tip designs, even for non-weeding purposes, such as a shovel or a pick.
    Type: Application
    Filed: May 21, 2021
    Publication date: November 24, 2022
    Inventor: Jerry Bryant O'Neil
  • Publication number: 20100278731
    Abstract: Compositions for imaging pancreatic beta cells comprise chelator-antidiabetic agent conjugates and optionally chelated metals.
    Type: Application
    Filed: November 2, 2009
    Publication date: November 4, 2010
    Inventors: David J. Yang, Chang-Sok Oh, Saady Kohanim, Dong-Fang Yu, Ali Azhdarinia, Jerry Bryant
  • Patent number: 7611693
    Abstract: Compositions for imaging pancreatic beta cells comprise chelator-antidiabetic agent conjugates and optionally chelated metals.
    Type: Grant
    Filed: September 16, 2004
    Date of Patent: November 3, 2009
    Assignee: Board of Regents, The Univerisity of Texas System
    Inventors: David J. Yang, Chang-Sok Oh, Saady Kohanim, Dong-Fang Yu, Ali Azhdarinia, Jerry Bryant
  • Publication number: 20050129619
    Abstract: The invention provides, in a general sense, a new labeling strategy employing compounds that are are N2S2 chelates conjugated to a targeting ligand, wherein the targeting ligand is a disease cell cycle targeting compound, a tumor angiogenesis targeting ligand, a tumor apoptosis targeting ligand, a disease receptor targeting ligand, amifostine, angiostatin, monoclonal antibody C225, monoclonal antibody CD31, monoclonal antibody CD40, capecitabine, a COX-2 inhibitor, deoxycytidine, fullerene, herceptin, human serum albumin, lactose, leuteinizing hormone, pyridoxal, quinazoline, thalidomide, transferrin, or trimethyl lysine. The present invention also pertains to kits employing the compounds of interest, and methods of assessing the pharmacology of an agent of interest using the present compounds.
    Type: Application
    Filed: December 10, 2003
    Publication date: June 16, 2005
    Inventors: David Yang, Dong-Fang Yu, Chang-Sok Oh, Jerry Bryant
  • Publication number: 20050100506
    Abstract: Compositions for imaging pancreatic beta cells comprise chelator-antidiabetic agent conjugates and optionally chelated metals.
    Type: Application
    Filed: September 16, 2004
    Publication date: May 12, 2005
    Inventors: David Yang, Chang-Sok Oh, Saady Kohanim, Dong-Fang Yu, Ali Azhdarinia, Jerry Bryant